AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On May 16, 2025,
experienced a significant drop of 10.41% in pre-market trading, raising concerns among investors and analysts alike.Needham & Company LLC recently revised their price target for Enovis, lowering it from $64.00 to $57.00 while maintaining a "buy" rating. This adjustment comes amidst a challenging period for the company, as its stock has declined by 22.5% over the past six months, currently trading at $31.96.
Canaccord Genuity also made changes to their financial outlook for Enovis, reducing the price target from $75.00 to $70.00. This adjustment reflects a 6.67% decrease and was made following the company's Q1 performance. The firm continues to hold a "buy" rating on the shares.
Enovis has also adjusted its guidance for the year, lowering its adjusted EBITDA by $20 million due to anticipated tariff impacts in the second half of 2025. This move has added to the uncertainty surrounding the company's financial health and future prospects.

Knowing stock market today at a glance

Dec.12 2025

Dec.12 2025

Dec.12 2025

Dec.12 2025

Dec.12 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet